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Understanding data on novel coronavirus (COVID-19) pandemic, and modeling such data 
over time are crucial for decision making at managing, fighting, and controlling the spread of this 
emerging disease.   This thesis work looks at some aspects of exploratory analysis and modeling 
of COVID-19 data obtained from the Florida Department of Health (FDOH). In particular, the 
present work is devoted to data collection, preparation, description, and modeling of COVID-19 
cases and deaths reported by FDOH between March 12, 2020, and April 30, 2021.  
 For modeling data on both cases and deaths, this thesis utilized an autoregressive 
integrated moving average (ARIMA) times series model. The “IDENTIFY” statement of  SAS 
PROC ARIMA suggests a few competing models with suggested values of the parameter p (the 
order of the Autoregressive model), d (the order of the differencing), and q (the order of the 
Moving Average model).  All suggested models are then compared using AIC (Akaike Information 
Criterion), SBC (Schwarz Bayes Criterion), and MAE (Mean Absolute Error) values, and the best-
fitting models are then chosen with smaller values of the above model comparison criteria. To 
evaluate the performance of the model selected under this modeling approach, the procedure is 
repeated using the first six month’s data and forecasting the next 7 days data, nine month’s data 
and forecasting the next 7 days data, and then all reported FDOH data from March 12, 2020, to 
April 30, 2021, and forecasting the future data. 
 The findings of exploratory data analysis that suggests higher COVID-19 cases for females 
compared to males and higher male deaths compared to females are taken into consideration by 
evaluating the performance of final models by gender for both cases and deaths’ data reported by 
FDOH. The gender-specific models appear to be better under model comparison criteria Mean 
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Absolute Error (MAE) and  Root Mean Squared Error (RMSE) compared to models based on 
gender aggregated data.  
It is observed that the fitted models reasonably predicted the future numbers of confirmed 
cases and deaths.  Given similarities in reported COVID-19 data, the proposed modeling approach 
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CHAPTER 1: BACKGROUND   
1.1 Introduction  
COVID-19 (Coronavirus disease 2019) is an infectious disease, which is first found at the 
end of 2019 in Wuhan, China [1]. COVID-19 leads to severe respiratory syndrome with other 
symptoms including acute/light fiver, shortness of breath, cough, muscle pain, headache, fatigue, 
and loss of smell and test [2]. In January  2020, the first COVID-19 was confirmed in the United 
State. Since the middle of February 2020, COVID-19 has been spreading in the community in the 
USA.  By April 30, 2021, more than 33.11 million were infected and over 590 thousand died in 
the USA [3]. On March 1, 2020, the first two COVID-19 confirm cases were reported in Manatee 
and Hillsborough counties of Florida, USA [12]. COVID-19, which is transmitted from person to 
person, is primarily spread between people during close contact, small droplets produced by 
talking, sneezing, and coughing [4]. 
In the beginning, the fight against COVID -19 appears to be not under control due to a lack 
of deep knowledge, insufficient information, and treatment.  As a result, COVID_19 has been 
spread so quickly that the number of confirmed cases of COVID-19 and death has been increasing 
day by day. COVID-19 has spread nationwide within a month since the first severe acute 
respiratory syndrome coronavirus infection in Washington state was confirmed on January 11, 
2020, by the US center for disease control and prevention. Although it has been more than one 
year since the first COVID 19 case was found in the USA, hundreds of deaths are still occurring 
daily all over the USA. Millions of Americans have lost their jobs and many more are only partially 




To minimize the effect of the COVID-19 pandemic, federal, state, and local governments 
responded with various declarations of emergencies, which resulted in travel and entry restrictions. 
To slow down the spread of COVID-19, different guidelines and recommendations are imposed, 
such as lockdowns, closure of schools, prohibit public gatherings, and imposed other restrictions. 
It has been claimed by several recent studies [5,6] that public health interventions, school closure, 
cordons sanitaire, traffic restriction, social distancing, stay-at-home order, face-masking all factors 
have a link to reduce the daily confirm cases and death of COVID-19. The stay-at-home order was 
first started in California on March 19, 2020. Until April 7, the number and proportion of 
implementing stay-at-home orders by other 39 states and DC have been increasing. On April 3, 
2020, nearly 85.2% of the U.S. population were under Stay-at-home order. [7]. 
 
                 Figure 1: State-mandated stay-at-home orders by date implementation [7]. 
In response to the COVID-19 pandemic, numerous stay-at-home orders (SAHO), such as 
curfew, quarantines, and similar restrictions are enforced locally and nationwide. However, the 
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effect of the state of home order is still unclear due to local factors, such as population densities, 
education institutes, businesses, and other local factors [8]. The stay-at-home orders are not 
directly correlating with controlling of COVID-19 spreading, which creates opportunities for 
researchers to estimate the effect of stay-at-home orders considering local factors, which vary 
spatially and temporally.  
To face this epidemic (COVID-19), public health experts, policymakers, partisans across 
the state, the federal government, and economists are depending on a statistical model to make 
predictions and evaluations to stay in a safe situation. Even though several steps have been taken 
to control this pandemic, it has not stopped. The current number of Deaths and Cases of COVID-
19 is decreasing from the end of January 2021. As the different types of vaccines of COVID-19, 
such as Pfizer-BioNTech, Moderna, and Johnson & Johnson’s, are now available in the USA, it is 
hoped that when most people are fully vaccinated this disease will be controlled.  However, it is 
not sure whether this number will increase again.  
To understand the future condition of COVID-19 Deaths and Cases good models are 
needed. There are several time series models for forecasting. However, the most used model is 
Autoregressive Integrated Moving Average (ARIMA) model. As the CODIV-19 dataset is a time-
series dataset, using the ARIMA model to forecast the COVID-19 cased and deaths will be a good 
choice. It is known that by using SAS software, proc ARIMA’s IDENTIFIED statement will give 
some suggestions to choose the best model parameters that will be helpful to forecast. In this study, 
we will justify those SAS suggestions based on COVID-19 cases and deaths in Florida.  
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1.2 COVID-19 and Current world 
COVID-19 is an infectious disease caused by a newly discovered coronavirus 2 (CoV-19). 
Mild to moderate respiratory illness (shortness of breath or breathing difficulties, fever, fatigue, 
loss of smell, and taste are the most common symptoms with COVID-19 [9]. When an infected 
person coughs and sneezes, the droplets of saliva or discharge from the nose spread everywhere 
around that person, which is the primary source of COVID-19 spreading. This may also spread 
from the touching of contaminated surfaces and then touching the mouth or face. Therefore, 
frequent hand washing, social distancing, quarantine, and face covers are recommended by health 
experts [10].  
COVID-19 vaccination is considered the main resource to help end the COVID-19 
pandemic. There are currently three COVID-19 vaccines authorized in the united states for 
emergency use: two mRNA vaccines (Pfizer-BioNTech, Moderna) and one viral vector vaccine 
(Janssen [Johnson & Johnson]). Even though there are serval vaccines that are approved for 
emergency use, COVID-19 is still spreading in the USA.  On vaccine trials, more than 70 
companies and research teams are working with five and six operating primarily in the united 
states.  
Figure 2 (a) shows the distribution of COVID-19 confirmed cases worldwide as of week 
19 2021 according to the European center for disease prevention and control (ECDC) and (b) 
shows the distribution of COVID-19 deaths worldwide as of week 19 2021.  It is clear that the 
united states still dominating on many death and cases than that of the rest of the world. More than 








Figure 2 : (a) Distribution of cases of COVID-19 pandemic and (b) Distribution of COVID-19 
deaths worldwide, by continent [11]. 
1.3 Motivation and Objectives 
We are living through a crisis that hasn’t been seen in 100 years. This not a crisis for a 
country and territory, it is a world crisis and is created by the COVID-19 pandemic. The impact 
and enormous scale of this crisis causing a lot of fear, uncertainty, and anxiety across the whole 
world. Researchers are trying to understand the different facts with COVID-19 and trying to bring 
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knowledge to us, which may create a better opportunity to face this pandemic.  The main purpose 
of this research is two folds: explore COVID-19 cases and deaths in Florida and develop statistical 
models for a better understanding of COVID-19 as it relates to the State of Florida.  The motivation 
of this research are summarized as follows: 
1. Florida is one of the most populated states in the United States with more than 21 
million populations. 
2. The economic impact of Florida is near the top among all states in the USA.  
3. Since Florida was hit very badly by the COVID-19 outbreak, this thesis is focused only 
on the State of Florida where government data from the Florida Department of Health 
(FDOH) is used and the number of cases and deaths are considered main variables to 
analyze.  
The objectives of this research are summarized as follows: 
1. Review literature on modeling efforts of COVID -19 data and identify knowledge 
gaps.   
2. Collect data from a reliable source. 
3. Explore and analyze data to identify and evaluate model performance by using a 
data-driven approach using COVID-19 cases and deaths in Florida. 
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CHAPTER 2: LITERATURE REVIEW  
2.1 Literature review   
An outbreak of novel coronavirus (COVID-19), which began in Wuhan China on 
December 31, 2019, and has spread rapidly to most of the countries in the world. According to the 
John Hopkins report [1], more than 166 million coronaviruses confirmed cases, and 3.4 million 
deaths are counted in worldwide. The World Health Organization (WHO) declared COVID-19 as 
a global pandemic on March 11, 2020 [2]. In history, the world has seen several pandemics and 
epidemics, including the 1918 Spanish flu, the 1957 Asian flu, and the 1968 Hong Kong flu 
pandemics [3].  
The most effective way to slow down the spread of the novel coronavirus is to maintain 
physical distance from person to person or “socially distance”, which has been recognized by both 
World Health Organization (WHO) and the Center for Disease Control (CDC).  The initial 
response for COVID-19 was slow, although the first confirmed case was reported on January 21, 
2020, national wide “state of emergency” was not declared until March 31, which is almost two 
months after the first confirmed case in the US [4]. The public health officials are implementing 
different orders and warnings, including social distancing, state at home, travel restriction, non-
essential businesses, lockdown, and schools, to mitigate the spread of COVID-19.  
In the United States, stay-at-home order was announced by California’s Governor in March 
2020 for residents to control the outbreak of COVID-19. After that different US states and 
territories started implementing community mitigation by the state at home order, which can lower 
the risk of disease transmission [5]. In the United States, each state or territory has its laws and 
policies to protect the public’s health that widely varied in type and timing of orders issued related 
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to the state-at-home ordered. Therefore, the effectiveness of the state-at-home order varied across 
the states and counties, which suggests the spatial and temporal variation for the effectiveness of 
the state at home orders and the broader impact of these stay at home orders is still not clear, which 
significantly attract researcher to investigate the effectiveness of the stay at home orders locally 
and also nationwide.  
 
Figure 3: Florida’s COVID-19  daily cases and deaths from March 24 to April 30, 2021 [6].  
Florida is one of the epicenters in the United States, which was hit very badly by the 
COVID-19 outbreak [7]. The reason for the higher number of COVID-19 cases could be related 
to ports of entry, including shipping ports and airports. Besides that, Florida is a large tourism 
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place and has an older age population. Florida has more than 2.2 million COVID-19 cases and 
more than 35 thousand deaths until April 2021 [8]. Aric Chokey in his report [6] displays in figure 
3, daily reported COVID-19 cases and deaths in Florida from March 24 to April 30, 2021. Florida 
gov. issued a state-wide at-home executive order on April 3, 2020, and the first phase of reopening 
begins on May 4, 2020. Mask mandates were issued in only a few counties or cities in Florida.  
To analysis, the effectiveness of stay-at-home orders, the response measures to the 
outbreak of COVID-19, the number of confirmed cases are the most frequently used parameters 
in different statistical study studies all over the world [9]. However, the COVID-19 case count is 
biased by the number of tests, test equipment, and other factors, therefore, the number of cases is 
somewhat not correct.  
The COVID-19 pandemic is adding a catastrophic impact in this world, almost every aspect 
of our life is affecting by this pandemic. The international statistics community has continued to 
work throughout this crisis and ensuring the best quality of data and statistics to support decision-
making during and after this pandemic. In this study, the number of COVID-19 cases and deaths 
are analyzed. 
Based on the COVID-19 dataset, many research works have been done and different types 
of papers have been published worldwide. Most of those tried to figure out the future condition of 
COVID-19. Even though different types of models are used to forecast the COVID-19, the more 
frequently used model to this time series data is the ARIMA model. A few of those papers that are 
related to current studies of this thesis have been discussed below: 
Gecili et al. [11] have forecasted COVID-19 confirmed cases, deaths, and recoveries by 
using different time series models. In this research, authors have used four different time series 
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models, which are cubic smoothing spline model, Holt model, Autoregressive Integrated Moving 
Average (ARIMA) model, and TBATS (Trigonometric Exponential smoothing state space model 
with Box-Cox transformation, ARMA errors, Trend, and Seasonal component) model, to forecast 
the COVID-19 confirmed cases, deaths, and recoveries and to compare the performance of these 
model based on mean absolute error (MAE), mean absolute percentage error (MAPE), and AIC 
(Akaike information criteria) by using R software. After analyzing those models, they concluded 
that the ARIMA model is the most useful model to do this type of analysis. 
Navid Nashinchi has used the time series model in his online article [12] (ARIMA 
MODEL) to predict the number of COVID-19 deaths for 21 days and compare the projection with 
CNN’s projection. He has used COVID-19 data of the USA from December 31, 2019, to August 
01, 2020. To do this analysis he used the R package. In his ARIMA model, the auto.arima function 
has suggested three parameters, such as p (autoregressive) = 3, d (integration) = 0, and q (moving 
average) = 2. The AIC value of this model is 3129.92 and the BIC value is 3150.11. 
Forecasting the future effect of confirmed cases of Coronavirus around the world by using 
time series COVID-19 data till June 26, 2020, have presented by Sujeet Maurya. In this aircle[13],  
analysis of the COVID-19 data is performed by using Python software with applying four methods, 
such as ARIMA, Holt’s Winter seasonal method, NAÏVE, and Holt’s linear trend method. In the 
ARIMA model with p = 0, q = 0, and d = 2, their MSE is found to be 7240024855.066816, AIC 
value is found to be 2855. The Root Mean Square Error is found to be 16680 for Holt’s linear trend 
method, and The Root Mean Square Error is 16789 for Holt’s Winter seasonal method. After 
comparing all four models, they conclude that as the MSE for NAÏVE (root mean square error is 
15580) is less than other models, therefore it is the best model for their dataset. However, he 
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suggested that as the data points are less in their analysis, it could be possible to be another model 
with high data points.  
Another example of using ARIMA is found in reference [14], where Facebook’s 
PROPHET Forecasting Model and ARIMA Forecasting Model have been used to forecast the 
trend of the COVID-19 disease in Indonesia and compared those models to get a better performer. 
They have forecasted 30 days by applying these two models based on the COVID-19 dataset in 
Indonesia that is taken from January 20, 2020, to May 21, 2020. They transformed the data in log-
scale to do this analysis. For confirmed variable their p = 22, d = 1 and q = 22, for deaths variable 
p = 3 and d = 1, and q = 3, and for recovered variable p (AR term) = 1, d (differencing) = 1, and p 
(MA term) = 1. In the ARIMA model, the MAE for confirmed Cases, Deaths and Recovered are 
found   2967, 617.6, and 961.167, respectively. In the PROPHET model, the MSE is less for each 
variable, such as MAE for confirmed Cases, deaths. and recovered are 686.3, 153.1. and 955.83, 
respectively. After justifying those two models by using MAE, they concluded that the PROPHET 
model is giving more accurate results for their dataset to forecast.   
By using the ARIMA model on the COVID-19 data till June 2020 Singh et al. [15] 
investigated the prediction forecast for August 2020. The purpose of this study is to find out the 
effect of unlocking in India by comparing the forecasted positive cases and the total number of 
tests conducted for COVID-19 in unlock and lockdown times. For this analysis, seven forecasting 
models, which are TBAT, Prophet, Auto-regressive Integrated Moving Average (ARIMA), 
Moving Average, Neural Basis Expansion Analysis (N-BEATS), Single Exponential Method, 
Double Exponential Method have been tested and compared based on the prediction accuracy. 
After justifying the root mean square error (RMSE), the ARIMA model was selected as the best 
forecasting model. In the ARIMA model, the Auto-correlation function (ACF) graph and partial 
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autocorrelation (PACF) graph have been used to get P(auto-regression) = 2 for lockdown time and 
1 for unlock time, Q (order of moving average) = 2 for lockdown time and 1 for unlocking time, 
and D ( degree of trend difference). Dickey-Fuller test has been done to find out whether data is 
stationary and log-transformed also has done to get stationery data.  
Another research work for forecasting COVID-19 has been done by Omaran et al. [ 16]. In 
this paper, the COVID-19 data from May 1, 2020, to December 6, 2020, has been used from three 
countries, such as Egypt, Saudi Arabia, and Kuwait. To do this study they used two deep learning 
Methods, one is Long short-term memory (LSTM) and gated recurrent unit (GRU). They have 
transformed data into two ways supervised learning and scaling. MAE, MAPE, and RMSE 
measures have been used to find out the best performer model. In their work, LSTM has shown 
the best result in the confirmed cases for those three countries. on the other hand, GRU has given 
the best performance in death cases for Egypt and Kuwait. 
The above-discussed models are really helpful to know the COVID-19 as they have shown 
much information about COVID-19. However, the MAE and AIC values of those previous studies 
are not always satisfactory. This can be happened for small size of data or can be happened for the 
inaccurate model selection. Therefore, there is a lot of doubt about the accuracy of those models' 
results. Since there are numerous available datasets on COVID-19 to avoid that confusion, SAS 
suggested selecting the ARIMA model with the best performer parameter (p, d, q) might be helpful. 
As SAS is statistical software that helps to analyze advanced data, it has several options to study 
with a time-series dataset. In SAS there is an identification option, which will represent different 
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CHAPTER 3: DATA COLLECTION AND PREPARATION 
3.1 Data Collection  
To understand the impact of COVID-19 across the world, accurate data is critical. To find 
out the risk factors for this severe disease and transmission, forecast the spread and impact, taking 
the proper step, measuring the impact of this disease on society, collection of COVID-19 Data was 
urgent. Besides that, to make people aware of the severity and spectrum of illness it is needed to 
collect all COVID-19 Data. From appropriate data, the world can have a better understanding, 
more appropriate response, estimating, and planning for the future impact of the pandemic like 
COVID-19. COVID-19 open-access data and computational resources are being provided by 
federal and worldwide agencies, including NIH, WHO, and state departments and private entities. 
These resources are freely available to researchers and the public. The most common open-access 
data resources are given below  
1. Johns Hopkins Coronavirus Resource Center [1].   
(https://github.com/CSSEGISandData/COVID-
19/tree/master/csse_covid_19_data/csse_covid_19_daily_reports_us) 
2. World Health Organization (WHO) Coronavirus Disease Dashboard [2] 
3. New York Times COVID-19 data [3]. 
      https://github.com/nytimes/covid-19-data/blob/master/us-counties.csv 
4. Florida Department of Health data [4]  
 




Florida COVID19 Case Line Data 2021 
https://open-fdoh.hub.arcgis.com/datasets/florida-covid19-case-line-data-2021-1/data 
5. Center for Disease Control and Prevention [5] 
https://data.cdc.gov/Policy-Surveillance/U-S-State-Territorial-and-County-Stay-At-
Home-Orde/qz3x-mf9n/data 
As this study focuses on the State of Florida, therefore “Florida Department of  Health 
Open Data” is used as a source for data in this study.  Florida department of health releases a report 
each day on the number of new COVID-19 confirmed cases, emergency visits, hospitalizations, 
and death [6]. This data includes daily COVID-19 cases and deaths with other related information 
at county levels. To collect data and include the most updated information in the analysis, this site 
was checked once a week.  
3.2 Data preparation     
Florida COVID-19 Case Line Data was collected from the Florida Department of Health 
Open Data source as a CSV format, where data for 2020 is available as Florida COVID-19 Case 
Line Data 2020 (https://open-fdoh.hub.arcgis.com/datasets/florida-covid19-case-line-data-
2020/data) and data for 2021 is available as Florida COVID-19 Case Line Data 2021 ( https://open-
fdoh.hub.arcgis.com/datasets/florida-covid19-case-line-data-2021-1/data ). As every day the 
number of deaths, cases, hospitalization, and emergency visits are changed, to update the dataset 
the page was checked weekly. Data was collected separately from those two links and then 
combined to make one dataset. The available data in those links have started from March 2, 2020, 
to the current date. The missing data was checked for all dates which are considered in this dataset. 
However, it is found that missing data are present only in a few rows. Therefore, to avoid those 
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missing values a few rows are omitted from the dataset, which confirmed that in the new dataset 
there are no missing values.  There were some issues with data with very few or a lot of missing 
data before March 12, 2020, thus data from March 12, 2020, to April 30, 2021, have been used.  
April 30 has been chosen as a cutoff date to get enough time to finish the analysis and write up the 
thesis work.   




Number of days  415 
Number of Cases  2237920 
Number of Deaths 36909 
 
In this dataset, the total row is 2237922 and there are a total of 12 variables such as County, 
Age, Age group, Gender, Edvisit, Hospitalized, Died, Case (Case_), Contact, Case1, EventDate, 







Table 2: List of variables and attributes  
Number Variable Type Format 
1 Age Char $3.00 
2 Age_group Char $11.00 
3 Case1 Num YYMMDD10. 
4 Case_ Char $3.00 
5 ChartDate Num YYMMDD10. 
6 Contact Char $7.00 
7 County Char $12.00 
8 Died Char $3.00 
9 EDvisit Char $7.00 
10 EventDate Num YYMMDD10. 
11 Gender Char $7.00 
12 Hospitalized Char $7.00 
 
To analyze this large data set, commercially available statistical software “SAS” is used. 
SAS Proc import datafile command is used to import the data in the SAS file. As mentioned earlier 
that the original dataset was downloaded as CSV. Table-3 shows the part of the dataset that 






Table 3: Dataset with different variables in the SAS file  




Case1 EventDate ChartDate 
Volusia 51 45-54 years Male NO NO NA Yes 2020-04-15 2020-03-23 2020-04-15 
Dade 47 45-54 years Male NO NO NA Yes 2020-04-15 2020-04-01 2020-04-15 
Dade 39 35-44 years Female NO NO NA Yes 2020-12-31 2020-12-31 2020-12-31 
Collier 12 5-14 years Female NO NO NA Yes 2020-11-02 2020-11-02 2020-11-02 
Hillsbor
ough 
55 55-64 years Female NO NO NA Yes 2020-10-26 2020-10-26 2020-10-26 
Volusia 21 15-24 years Female UNKNOW
N 
UNKNOWN NA Yes 2020-10-26 2020-10-26 2020-10-26 
St. Lucie 62 55-64 years Male NO NO NA Yes 2020-10-26 2020-10-26 2020-10-26 
Polk 21 15-24 years Male UNKNOW
N 
UNKNOWN NA Yes 2020-10-26 2020-10-26 2020-10-26 
Dade 10 5-14 years Male NO NO NA Yes 2020-10-26 2020-10-24 2020-10-26 
Orange 16 15-24 years Female NO NO NA Yes 2020-11-05 2020-11-03 2020-11-05 
 
In the main dataset variables “Jurisdiction”, “Travel_related”, “Origin”, “Contact” and 
“ObjectId” are included. However, those variables have been dropped from the original dataset as 
these variables are not considered for analysis and a new dataset is created. After eliminating these 
variables from the original dataset, the dependent variable will not be affected. In this dataset, 
dates are presented based on three types of dates, which are Case1, EventDate, and ChartDate. 
However, Case1 is considered as the exact date of the COVID-19 case. Therefore, the name of the 
variable “Case1” is changed to “Date”.   
In the original dataset, data are imputed randomly with a different date. Therefore, it has 
been sorted by the “Date” variable to represent the data in a more organized way that will help to 
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understand data easily. Since there are 22,37,922 rows in this dataset, only ten among them are 
shown in table-4, which started on March 12, 2020. 
Table 4: Dataset in sorted based on the Data variable 
County Age Age_group Gender EDvisit Hospitalized Deaths Cases Date 
St. Johns 63 55-64 years Male YES YES NA Yes 2020-03-12 
Broward 70 65-74 years Male YES YES Yes Yes 2020-03-12 
Lee 57 55-64 years Male NO NO NA Yes 2020-03-12 
Broward 65 65-74 years Male NO NO NA Yes 2020-03-12 
Broward 61 55-64 years Male YES NO NA Yes 2020-03-12 
Dade 56 55-64 years Male YES NO NA Yes 2020-03-12 
Seminole 68 65-74 years Male YES NO NA Yes 2020-03-12 
Palm Beach 73 65-74 years Male YES YES Yes Yes 2020-03-13 
Broward 20 15-24 years Female YES YES NA Yes 2020-03-13 
Duval 83 75-84 years Male YES YES Yes Yes 2020-03-13 
 
Then a dataset has been created by using the total count of Cases, and Deaths against each 
date to do more analysis. An id variable is also created to make analysis easier. There is a total of 






Table 5: Dataset with daily COVID-19 Cases, and Deaths 
Date Cases Deaths id 
2020-03-12 7 1 1 
2020-03-13 24 5 2 
2020-03-14 45 2 3 
2020-03-15 33 4 4 
2020-03-16 31 4 5 
2020-03-17 70 4 6 
2020-03-18 107 7 7 
2020-03-19 87 5 8 
2020-03-20 150 11 9 
2020-03-21 217 15 10 
2020-03-22 306 17 11 
2020-03-23 193 16 12 
2020-03-24 299 20 13 
2020-03-25 515 33 14 
2020-03-26 560 27 15 
2020-03-27 689 59 16 
2020-03-28 728 43 17 
2020-03-29 909 57 18 
2020-03-30 897 55 19 
2020-03-31 937 42 20 
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CHAPTER 4: DATA DESCRIPTION  
4.1 Descriptive Analysis    
The daily cases and deaths in Florida from March 12, 2020, to April 30, 2021, are 
calculated using SAS PROC FREQ.  There were 2237920 cases and  36909 deaths during the 
period mentioned above. The daily number of cases is displayed below.  
 
Figure 4: Daily COVID-19 cases from March 12, 2020, to April 30, 2021, in Florida 
  
Figure 4 shows the daily number of COVID-19 cases in Florida. In this figure,  there are 4 
peaks. The first peak happened in April 2020, the second peak was in July 2020, the third peak 
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that is the highest peak until April 30, 2021, was in January 2021, and the fourth peak was in April 
2021. 
Similarly, the frequency analyses were performed for daily deaths and are displayed below:  
 
Figure 5: Daily COVID-19 deaths from March 2020 to April 2021 in Florida 
Figure 5 shows daily COVID-19 deaths in Florida. From this figure, it can be seen that the 
highest number of deaths was happening in July 2020. In this figure, there are three peaks for daily 
COVID-19 deaths. The first peak was in April 2020, the second peak was in July 2020, and the 
third peak was in January 2021. 
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CDC reported that male patients are dying more than female patients for COVID-19 
disease worldwide [1]. Florida data also suggested that the number of deaths for male patients is 
higher than that of females for COVID-19, even though the number of cases is higher for female 
patients compared to male.  In table 6, it is shown that the total number of cases for females is 
1168825 and that for males is 1049716 whereas the total number of deaths of females is 16153 
and males are 20756 from March 12, 2020, to April 30, 2021.   
Table 6: Total Number of COVID-19 Cases and Deaths for Female and Male in Florida 
 
Gender Cases Deaths 
Female 1168825 16153 
Male 1049716 20756 
Unknown 19379    0 
 
To explore further how gender relates to deaths and cases here in Florida, the  daily cases 









It can be seen from this figure 6 that even though some of the point the number of cases 
for both genders overlap, most of the time daily COVID-19 cases of the female are more than that 
of male in Florida. So, not only the total number of COVID-19  cases is higher for females but 
also the daily number of COVID-19  cases is higher for them than that of males in Florida. 
Therefore, females are more affected by COVID-19 compare to males in Florida.  
As the overall COVID-19 deaths are high for male patients, to see the daily COVID-19 
deaths in Florida the plots of Date variable vs Deaths variable based on gender have been drowned. 
From this daily COVID-19 deaths plot, it is seen that in most of the cases the daily deaths for 
COVID-19  male patients are more than that of COVID-19 female patients (Figure 7).  
After observing those two plots (Figure 6 and Figure 7) it is clear that the total number of 
cases and deaths in Florida are showing different results. Even though the number of daily COVID-
19 cases is confirmed more for females, the number of deaths of daily COVID-19 is higher for 





Figure 7: Daily COVID-19 deaths of male and female in Florida 
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Table 7 displays the cases and deaths by both age group and gender.   It appears that females 
between 25 and 34 years are affected more than any other age group. However, the number of 
deaths for male patients is highest (6507) in the age group 75 to 84.  
Table 7: Total Number of  Cases and Deaths for Male and Female based on Age_group 
Age_group Gender Cases Deaths 
 
0-4 Years  
Female 22504 1 




Female 71970 4 
Male 73416 1 
 
15-24 Years  
Female 184835 24 
Male 162237 28 
 
25-34 Years  
Female 206101 91 
Male 183137 135 
 
35-44 Years  
Female 182850 225 
Male 162040 381 
 
45-54 Years  
Female 176829 542 
Male 159349 973 
 
55-64 Years  
Female 150906 1538 
Male 138399 2623 
 
65-74 Years  
Female 92681 3052 
Male 84248 4887 
 
75-84 Years  
Female 51590 4645 
Male 45594 6507 
 
85+ Years  
Female 28046 6031 
Male 16813 5220 
 
Unknown  
Female 513 0 





Figure 8: COVID-19 cases for male and female based on different Age_group 
When the number of cases of COVID-19 patients vs Age_group based on gender plot is 
drowned, it is seen that the female whose age is in 25-34 Age_group are confirmed more COVID-





Figure 9: COVID-19 deaths for male and female based on different Age_group 
Figure 9 displays that the number of deaths of COVID-19 is increasing for male and female 
patients with increasing of ages. The male patients, whose age is between 75 and 84, were dead 
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CHAPTER 5: METHODS AND MODEL   
5. 1 Time series ARIMA model    
A sequence of data on an outcome variable of interest observed at successive equally 
spaced points in time is referred to as time-series data. The time-series data considered in this 
thesis consists of daily counts of cases and deaths due to Covid-19 in the State of Florida from 
March 12, 2020, to April 30, 2021.   
The time series modeling approach, proposed by Box and Jenkins (1970), is used to predict 
a value in a  stationary response time series {Yt, t = 1, 2, … n}  as a linear combination of its past 
values, past errors, and current and past values of related other time series.   More specifically, this 
modeling approach combines an autoregressive model AR(p) and a  moving average model 
MA(q)   where AR(p) uses p-lagged values of the outcome variable for predictions and MA(q) 
uses the series mean and q-lagged errors for predictions.  These two models are displayed below. 
AR(p) Model: 
𝑦𝑡 = 𝑘 + ∅1𝑦𝑡−1 +  ∅2𝑦𝑡−2 +  ∅3𝑦𝑡−3 + ⋯ + ∅𝑃𝑦𝑡−𝑝 +  𝜀𝑡                               (1) 
In the above AR(p) model,  k is the constant,  𝑦𝑡−1, 𝑦𝑡−2, 𝑦𝑡−3, and  𝑦𝑡−𝑝 are p lagged values of 
the outcome variable Yt with corresponding parameters ∅1, ∅2, …,   ∅𝑝, and 𝜀𝑡 is the white noise. 
MA(q) Model: 




In the moving average MA(q) model,  𝑦𝑡 is considered as a weighted average of the past q 
forecast errors and c is the expectation of the series (𝑦𝑡),  𝜃1, … … , 𝜃𝑞  are the parameters of the 
model and 𝜀𝑡  , 𝜀𝑡−1…, 𝜀𝑡−𝑞   are white noise error terms. The combined AR(p) and MA(q)  model  
referred to as ARMA(p,q) model may be displayed as follows: 
𝑦𝑡  = 𝜇 + ∅1𝑦𝑡−1 + ⋯ + ∅𝑝𝑦𝑡−𝑝 + 𝜀𝑡 − 𝜃1𝜀𝑡−1 − ⋯ − 𝜃𝑞𝜀𝑡−𝑞                            (3) 
In ARMA(p, q) model (3), the predictors consist of lagged values of the dependent variable 
as well as lagged forecast errors and thus the predicted value of outcome variable Y is a weighted 
sum of p recent values of Y and q recent values of the errors. However, the above model is 
appropriate whenever the time series is stationary. Note that a time series is said to be stationary 
if its mean, variance, autocorrelation, etc., remain constant over time.  If a time series is 
nonstationary, then often differences are taken to achieve stationarity, and then the ARMA model 
is used on the differenced values Zt (say) of the time series (simply replace yt by zt in the model 
(3)). The resulting model is then referred to as the autoregressive integrated moving average 
(ARIMA(p, d, q)) model where d is the number of differences used to achieve stationarity.  
Proc ARIMA  developed by SAS  provides a comprehensive set of tools for univariate time 
series model identification, parameter estimation, and forecasting.  In this thesis, we have utilized 
Proc ARIMA’s  “IDENTITY” statement  for model identification and  “FORECAST” for 
forecasting using the following steps: 
• Check stationarity using rolling mean and rolling standard deviation, and Augmented 
Dickey-Fuller (ADF) Tests 
• Transform  data to achieve stationarity  
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• Use PROC ARIMA (p, d, q) on transformed data  to identify appropriate values of p, 
d, and q using IDENTIFY statement 
• Use model comparison criteria AIC, SBC to choose a given set of values of p, d, and 
q for the forecast model that appear to be a good fit for our data 
• Find model coefficients that provide the best fit for our data. 
• Test the models’ assumptions. 
• Compare model with previously known models by using MAE 
• Use the chosen model for forecasting. 
These steps are discussed below in more detail using COVID-19 Cases and Deaths data 
reported by the Florida Department of Health from March 12, 2020, to April 30, 2021. 
5. 2 Strategy for developing the ARIMA model of COVID-19 data in Florida  
In this study, the performance of proc ARIMA’s identify statement has been evaluated, 
where forecasting of the COVID-19 Deaths and Cases has been also done.  
Time series data can be stationary or nonstationary, therefore it needs to figure out that our 
data is stationary or non-stationary. In addition, the ARIMA model requires to have stationary 
form, which is also required to check stationarity before using the ARIMA model. When the mean 
and variance of data are constant over time that means the data has stationarity. The 7 days rolling 
mean and standard deviation have been performed in this study to check stationarity as reported in 
different articles on COVID-19 data [2]. After performing a rolling mean and standard deviation 
for 7- days, non-stationarity has been observed, which are shown in Figures 10(a) and 10(b).  
Figure 10(a) shows the rolling mean and standard deviation data for the number of COVID-19 
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cases and Figure 10(b) shows the rolling mean and standard deviation for the number of COVID-
19 deaths.  
 
Figure 10: (a) The rolling mean and standard deviation of the number of COVID-19 cases and(b)  
The rolling mean and standard deviation of the number of COVID-19 deaths 
From figure 10(a,b) it can be concluded that the mean and variance of COVID-19 cases 
and deaths are not constant and both go ups and down over time. Therefore, this time series data 
is not stationary.  
There are different ways to make the time-series data stationary, where log transformation 
of data can provide constant variance, and differencing (different between consecutive 
observations) can give constant mean [3]. Therefore, the log-transformed has been performed in 
this study to get data with constant variance. Some part of this log-transformed dataset has been 




Table 8: Dataset with log-transformed of COVID-19 Cases, and Deaths variables 
Date Cases Deaths id Log_Cases Log_Deaths 
2020-03-12 7 1 1 1.94591 0.00000 
2020-03-13 24 5 2 3.17805 1.60944 
2020-03-14 45 2 3 3.80666 0.69315 
2020-03-15 33 4 4 3.49651 1.38629 
2020-03-16 31 4 5 3.43399 1.38629 
2020-03-17 70 4 6 4.24850 1.38629 
2020-03-18 107 7 7 4.67283 1.94591 
2020-03-19 87 5 8 4.46591 1.60944 
2020-03-20 150 11 9 5.01064 2.39790 
2020-03-21 217 15 10 5.37990 2.70805 
2020-03-22 306 17 11 5.72359 2.83321 
2020-03-23 193 16 12 5.26269 2.77259 
2020-03-24 299 20 13 5.70044 2.99573 
2020-03-25 515 33 14 6.24417 3.49651 
2020-03-26 560 27 15 6.32794 3.29584 
2020-03-27 689 59 16 6.53524 4.07754 
2020-03-28 728 43 17 6.59030 3.76120 
2020-03-29 909 57 18 6.81235 4.04305 
2020-03-30 897 55 19 6.79906 4.00733 
2020-03-31 937 42 20 6.84268 3.73767 
Transforming COVID-19 data in the log-transformation format, it is found that the variance 
is approximately constant. Figures 11(a) and 11(b) are showing the rolling mean and standard 
deviation for the logarithm of COVID-19 cases and deaths, respectively. It is obvious from figure 
11 (a,b) that the mean for the logarithm of COVID-19 cases and deaths are both not constant. 




Figure 11: (a) the rolling mean and standard deviation for the logarithm of COVID-19 cases, and 
(b) the rolling mean and standard deviation for the logarithm of COVID-19 deaths. 
After differencing the COVID-19 data, it can be seen that the mean and variance are close 
to being constant. In figures 12 (a) and 12 (b) are representing the rolling mean and standard 
deviation for one difference of the COVID-19 log_cases and log_deaths, respectively  
 
Figure 12: (a) the rolling mean and standard deviation for the COVID-19 log_Cases, and (b) the 
rolling mean and standard deviation for the  COVID-19 log_Deaths after differencing the data ( 
the period of difference = 1) 
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However, to get a clear scenario of the stationarity of COVID-19 data more analysis has 
been done by using proc arima procedure, which will be discussed below. The outputs of 
log_Cases and log_Deaths variables by using the time-series model (ARIMA model) will be 
discussed separately in this part. At first, the finding results of the log_death variable are given. 
Table 9: Time series procedure- Input Data Set 
Input Data Set 
Name WORK. LOG_COVID_19 
Label   
Time ID Variable Date 
Time Interval DAY 
Length of Seasonal Cycle 7 
Table 9 represents the name of the dataset that is log_COVID_19, where the Time ID Variable is  
Date, and the Time Interval is Day with seven seasonal Cycle. 
Table 10: Time series procedure-Variable Information 
Variable Information 
Name Log_Deaths 
Label   
First 12MAR2020 
Last 30APR2021 
Number of Observations Read 415 
 
In this time series analysis, the used variable is log_Deaths (log-transformed of Deaths 
variable) and a total of 415 observations is considered. A plot has been shown below with log-





Figure 13: Log_Deaths is shown as a function of the Date 
Figure 13 shows daily COVID-19 log_Deaths in Florida, where the highest peak was in 
January 2021. There are three stages of ARIMA modeling, such as identification stage, estimation 
and diagnostic checking stage, and forecasting stage. All of these stages are discussed one by one. 
5. 3 Model Identification for log_Deaths variable 
IDENTIFY statements can be used to specify the response series and find out possible 
candidates for ARIMA models, where this statement is used to read the log_Deaths series and 
analyze its correlation properties in this study. In the identification stage, log_Deaths series are 
changed from nonstationary to stationary by one period of differencing. After using the period of 
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differencing 1, the mean of the log_Deaths series is 0.006697 that is close to zero and the standard 
deviation is 0.352396 (table 11). 
Table 11: Descriptive Statistics for log_Deaths series. 
Name of Variable = log_Deaths 
Period(s) of Differencing 1 
Mean of Working Series 0.006697 
Standard Deviation 0.352396 
Number of Observations 414 
Observation(s) eliminated by differencing 1 
  
In the identification stage, the white noise of time series data has been done as it is not 
possible to build a time series model with white noise. To check white noise a hypothesis test has 
been used. The results are described below:   
                Null Hypothesis:              log_Deaths series data with white noise; 
Research Hypothesis:     log_Deaths series data without white noise; 
In this case, the white noise hypothesis is rejected rigorously. As the p-value for the test of 
the first six autocorrelations is <0.0001, which means that the p-value is less than alpha 0.05. So, 
the null hypothesis is rejected. Therefore, this time series data is without white noise. So, building 




Table 12: Autocorrelation Analysis of log_Deaths series. 
Autocorrelation Check for White Noise 
To Lag Chi-Square DF Pr > ChiSq Autocorrelations 
6 70.02 6 <.0001 -0.401 0.015 -0.041 -0.070 0.022 -0.011 
12 113.36 12 <.0001 0.263 -0.010 -0.045 -0.032 -0.124 0.120 
18 167.62 18 <.0001 -0.128 0.285 0.017 -0.103 0.014 -0.131 
24 180.52 24 <.0001 -0.004 0.062 0.134 0.020 -0.038 -0.076 
  
In the ARIMA procedure, IDENTIFY statements normally generate some plots, such as 
the time series plot of the series, the sample autocorrelation function plot (ACF), the sample 
inverse autocorrelation function plot (IACF), and the sample partial autocorrelation function plot 
(PACF). Among them, the ACF plot is used to determine whether the dataset is stationary or non-
stationary, and the Augmented Dickey-Fuller (ADF) tests are also done to find out whether data 
is stationary or nonstationary.  
In Figure 14, it has been shown that ACF does not decay slowly rather than the 
autocorrelations in the ACF plot changes rapidly. Thus, the series of log_Deaths is considered 
approximately stationary data. 
 To be more confirm that the series of log_Deaths is stationary data, the Augmented 
Dickey-Fuller (ADF) test has been performed.  
From table 12 the p-values of the tau test, Rho test, and F test for all three models, such as 





Figure 14: Autocorrelation Analysis Plots for stationary series of the log_Deaths. 
The Extended Sample Autocorrelation Function (ESACF) table that recommends different 
values for parameters, p (the order of the Autoregressive model), d (the order of the differencing) 
and q (the order of the Moving Average model) based on the significance level specified by the 
ALPHA = 0.05 has been considered in this analysis to get one or more ARIMA models by using 
esacf option in the IDENTIFY statement. Then the performances of those recommended 
parameters have been evaluated by using the first six month’s data and forecasting the next 7 days’ 
data, nine month’s data and forecasting the next 7 days’ data, and then all reported FDOH data 
from March 12, 2020, to April 30, 2021, and forecasting the future data. 
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Table 13: Augmented Dickey-Fuller (ADF) Tests 
Augmented Dickey-Fuller Unit Root Tests 
Type Lags Rho Pr < Rho Tau Pr < Tau F Pr > F 
Zero Mean 0 -578.322 0.0001 -31.99 <.0001     
  1 -811.190 0.0001 -20.25 <.0001     
Single Mean 0 -578.445 0.0001 -31.96 <.0001 510.67 0.0010 
  1 -812.395 0.0001 -20.24 <.0001 204.75 0.0010 
Trend 0 -580.543 0.0001 -32.08 <.0001 514.58 0.0010 
  1 -830.794 0.0001 -20.44 <.0001 208.92 0.0010 
 
Table 14: SAS recommended ESACF (Extended Sample Autocorrelation Function) Tables for 





Table 14 shows SAS suggestion of the following parameters to fit one or more ARIMA 
models for the first six months’ data, nine months’ data, and from March 12, 2020, to April 30, 
2021 data in Florida. 
5.4 Estimation and diagnostic checking for log_Deaths variable 
ESTIMATE statement has been used to specify the ARIMA model to fit log-Deaths 
variable and to estimate the best parameters of that model. The recommendation for parameters 
(p, d, and p) specified in the previous IDENTIFY statement has been justified in this stage. As the 
period of differencing 1 has been used to make data stationery, the first recommendation of the 
ESACF table, (p+d, q) = (0,7), has been ignored. Then different models with those suggested 
parameters of ESACF tables have been fitted and compared with each other based on  AIC (Akaike 
Information Criterion) values, SBC (Schwarz Bays Criterion) values, and convergency problems 
for approximately six months’ data (from March 12, 2020, to September 10, 2020), for 
approximately 9 months’ data (from March 12, 2020, to December 09, 2020), and for 
approximately 13 months data (from March 12, 2020, to April 30, 2021) of Florida. In each case, 
p+d = 1 and q = 7 has been performing the best across all recommended parameters of ESACF 
tables.  
After building models with parameters p+d = 1 and q = 7, significant parameters of those 
models at alpha 0.05  have been found by observing the Maximum Likelihood Estimation tables 
that are produced by the ESTIMATE statement. From the Maximum Likelihood Estimation table, 
it has been seen that the MA1,1; MA1,6; and MA1,7 are significant parameters at alpha 0.05 as 
their p-values are less than 0.05  for 9 months’ data (from March 12, 2020, to December 09, 2020), 
and 13 months data (from March 12, 2020, to April 30, 2021) of Florida. However, for the first six 
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months’ data (from March 12, 2020, to September 10, 2020) MA1,1; and MA1,7 are only 
significant at alpha 0.05. As including MA1,6 in the model provides smaller AIC and SBC values 
and improves the overall performance of the model, it has been kept. Therefore, p=0, d = 1  and q 
= (1, 6, 7)  parameters are used to build these models. For the Chosen ARIMA model of six months, 
nine months, and thirteen months, the fitting of a constant parameter is suppressed as the constant 
term has been added little to the model. 
 The three fitted equations of ARIMA model (p = 0, d = 1,  q = (1, 6, 7) for COVID-19 
log_Deaths are shown below, where zt is the predicted value of log(yt) – log(yt-1): 
Six months 
𝑧𝑡 =  𝑒𝑡 − 0.5231 𝑒𝑡−1 +   0.0997𝑒𝑡−6 + 0.26361 𝑒𝑡−7                                (4) 
Nine months 
                 𝑧𝑡 =  𝑒𝑡 − 0.59242 𝑒𝑡−1 +  0.14668 𝑒𝑡−6 + 0.19463  𝑒𝑡−7                           (5) 
Thirteen months 
𝑧𝑡 =  𝑒𝑡 − 0.62506 𝑒𝑡−1 + 0.13609 𝑒𝑡−6 + 0.1714 𝑒𝑡−7                               (6) 
To know whether the model is fully adequate for those series, the autocorrelation of 
residuals has been checked. As the p-values of the first six lags are higher than the alpha value 
0.05, the null hypothesis-no-autocorrelation hypothesis is not rejected for all three periods of 
models (first six months, nine months, and thirteen months). Therefore, the ARIMA models with 
parameters (p = 0, d = 1, and q = (1, 6, 7)) are adequate to do this analysis. To be more confirm 
the graphical checks have also been done. Normality of residual has also been checked by using 
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normality plots that represent that there is no departure from normality for this ARIMA model (p 
+d = 1, q = (1, 6, 7)) for all three periods of models.  
 
5.5 Forecasting for COVID-19 log_Deaths   
 
By using the developed ARIMA model, log_Deaths of COVID-19 in Florida within seven 
days have been forecasted. To forecast this short-term future values of deaths series, the 
FORECAST statement has been used for the model with the first six months data, the nine months 
data, and thirteen months data. SAS given results for those months' models are discussed one by 
one. 
5.5.1 First Six Months 
 
FORECAST statement gives the next 7 days' forecasted values with standard error and 
95% confidence limits for the forecast. Table 15 represents the forecasted seven days’ values, 
where it can be seen that even though the number of log_Deaths would decreasing for some days, 
the number of log_Deaths would be increasing again. 
In figure 15, it is obvious that the ARIMA model (p = 0, d = 1,  q = (1, 6, 7)) predicted the 
number of log_deaths would be decreasing till September 14, 2020, then the number of log_deths 






Table 15: Forecast for the ARIMA (p = 0, d = 1, q = (1, 6, 7)) model for log_Deaths variable of 
the first six month’s data. 
Forecasts for variable log_Deaths for First Six months 
Obs Forecast Std Error 95% Confidence Limits 
184 4.2286 0.2918 3.6566 4.8006 
185 4.1204 0.3233 3.4867 4.7541 
186 4.0428 0.3520 3.3529 4.7327 
187 3.9260 0.3785 3.1841 4.6678 
188 4.0435 0.4033 3.2531 4.8340 
189 4.1124 0.4266 3.2762 4.9486 
190 4.1560 0.4586 3.2572 5.0549 
 
 
Figure 15: Forecast of log_Deaths for the ARIMA model (p = 0, d = 1,  q = (1, 6, 7)) for next 7 
days first six month’s data with 95% confidence limits. 
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Then daily’s actual log_Deaths and predicted log_Deaths have been compared from March 
12, 2020, to September 10, 2020, where the next seven day’s forecasted number of log_deaths is 
shown in Figure 16 (a). Here, the figure shows that actual values and predicted values support each 
other with very minimum error.  
 
Figure 16: Daily covid-19 actual log_Deaths and predicted log_Deaths for the first six months 
and forecasted log_Deaths for the next seven days in Florida. 
To see a better picture of COVID-19 deaths for the first six months with seven days of 




Figure 17: Comparing daily COVID-19  actual deaths and predicted deaths for the first six 
months and forecasted deaths for the next seven days. 
In the previous figure, it has been shown that the ARIMA model (p = 0, d = 1, q = (1, 6, 
7)) forecasted that the deaths would be decreasing until September 14, 2020, and would be 
increasing till September 17, 2020. To justify this model’s forecasting the actual number of deaths 
from March 12 to September 17 has been used. Figure 18 shows both actual deaths, and forecasted 
deaths, which are supported each other. Therefore, this indicates developed model has been 





5.5.2. FIRST Nine months: 
 
As shown previously, similar work has been done for Nine months duration. ARIMA (p = 
0, d = 1,  q = (1, 6, 7)) model of nine months gives the forecasted values of the log_Deaths for the 
next seven days that are given below: 
Table 16: Forecast for the ARIMA (p = 0, d = 1,  q = (1, 6, 7)) model for log_Deaths variable of 
the first nine month’s data. 
Forecasts for variable log_Deaths for Nine Months 
Obs Forecast Std Error 95% Confidence Limits 
274 5.1301 0.3009 4.5405 5.7198 
275 5.1656 0.3249 4.5288 5.8023 
276 5.0872 0.3473 4.4066 5.7678 
277 4.9996 0.3683 4.2778 5.7214 
278 4.9673 0.3882 4.2066 5.7281 
279 5.0613 0.4071 4.2635 5.8591 
280 5.1525 0.4399 4.2904 6.0147 
 
From table 16 is obvious that even though the number of  COVID-19 log_Deaths was 
decreasing until December 14, 2020, that was starting to increase again. The same things are shown 




Figure 18: Forecast of log_deaths for the ARIMA model (p = 0, d = 1, q = (1, 6, 7)) for the next 
7 days of the first nine months’ data with 95% confidence limits. 
For Nine months' durations, it is also shows developed ARIMA model has predicted the 
number of COVID-19 deaths fairly enough. In figure 19, the log number of COVID-19 deaths of 
actual and predicted values are shown for nine months duration, and also included 7 days 
forecasting based on the developed model, which is developed from the nine months actual data. 




Figure 19: Daily covid-19 actual log_deaths and predicted log_Deaths for the first Nine months 
and forecasted log_Deaths for the next seven days. 
In figure 20, the number of COVID-19 deaths of actual and predicted values are shown for 
Nine months duration without log values and also 7 days of forecasting data, where the comparison 
between the actual value and forecast value are represented with green dash lines. As mentioned 
above, these forecasted values are obtained from the developed ARIMA model suggested by SAS, 
and this model is based on the first nine months' data. For nine months of data, it is found that the 
developed model in this study has been able to forecast short-term duration well enough that 




Figure 20: Comparing daily COVID-19  actual deaths and predicted deaths for the first nine 
months and forecasted deaths for the next seven days. 
5.5.3 Thirteen months: 
 
Now the seven days’ forecasted values that are gotten by the developed ARIMA model are 
shown in table 17, where it can be seen that the COVID-19 log_Deaths are decreasing. Figure 22 






Table 17: Forecast for the ARIMA (p = 0, d = 1,  q = (1, 6, 7)) model for log_Deaths variable of 
thirteen months’ data. 
Forecasts for variable log_Deaths for Thirteen Months 
Obs Forecast Std Error 95% Confidence Limits 
416 2.7682 0.2877 2.2043 3.3322 
417 2.7409 0.3073 2.1386 3.3432 
418 2.7849 0.3257 2.1465 3.4232 
419 2.8147 0.3431 2.1422 3.4871 
420 2.7460 0.3596 2.0411 3.4509 
421 2.6463 0.3755 1.9104 3.3823 





Figure 21: Forecast of log_deaths for the ARIMA model (p = 0, d = 1,  q = (1, 6, 7)) for the next 




For thirteen months duration, like previous work, the same work has been done by 
considering the developed ARIMA model (p = 0, d = 1,  q = (1, 6, 7)).  
 
 
Figure 22: Daily covid-19 actual log_deaths and predicted log_Deaths for the thirteen  months 
and forecasted log_Deaths for the next seven days 
Figure 22 represents the log number of COVID-19 deaths of actual and predicted values 
for thirteen months duration with seven days forecasting based on the developed ARIMA model. 
Then to see the results more clearly figure 24 has been drowned, where without log data has been 
taken. In figure 23, a comparison of daily COVID-19  actual deaths and predicted deaths for the 
thirteen months with forecasted Cases for the next seven days has been shown, where it is obvious 
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that the actual deaths would be decreased after April 30, 2021, and the developed model also 
forecasted that the next seven days’ deaths would decrease.  
 
Figure 23: Comparing daily COVID-19  actual deaths and predicted deaths for the thirteen 
months and forecasted deaths for the next seven days. 
Now to compare these three models, more analysis has been done using MAE (Mean 
Absolute Error) and RMSE (Root Mean Squared Error). In table 18, MAE values and RMSE 
values are given for six months, nine months, and thirteen months duration. However, when other 
journals have been reviewed, it is found [4] that MAE is 617.6 and MSE is 388366.67 by using 
the ARIMA model (p+d = 4, q = 3). Therefore, MAE and RMSE values for all three models are 
comparatively low than recently published work for those kinds of studies. As shown before, all 
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three models are forecasted the number of COVID-19 deaths for a short-term duration, which is 7 
days in this study, quite enough to do further analysis. 
Table 18: Evaluation Metrics for the ARIMA Model (p = 0, d = 1,  q = (1, 6, 7)) 
 
Evaluation Metrics for the ARIMA Model (p = 0, d = 1, and q = (1, 6, 7)) 
for COVID-19 Deaths 
 Six Months Nine Months Thirteen Months 
Mean Absolute Error (MAE) 20.22 21.26 17.84 
Root Mean Squared Error 
(RMSE) 
30.62 36.40 25.56 
 
Satrio et al [4] Found in their study that MAE is 617.6 and MSE is 388366.67 (or equivalent 
Root Mean Squared Error = 623.19) by using the ARIMA model (p+d = 4, q = 3) for COVID-
19 deaths. 
Therefore, it can be said that the MAE and RMSE found for proposed models in this 
analysis are lower than those found elsewhere in the literature. 
Previously shown that the total number of COVID-19 Deaths for males is higher than that 
of females, and the daily deaths are also mostly higher for males. Now to see the effect of gender 
in forecasted COVID-19 deaths, the fitted ARIMA model (p = 0, d = 1, q = (1, 6, 7)) for log_Deaths 
has been fitted again based on gender, where this developed model is fitted for male and female 





Figure 24: Daily COVID-19  actual Deaths and predicted Deaths for the thirteen months and the 
next seven days’ forecasted deaths by ARIMA model (p = 0, d = 1, q = (1, 6, 7)) based on Male. 
Figure 24 shows the daily COVID-19 deaths for thirteen months, where actual death and 
predicted deaths are compared, and also forecasted deaths for seven days after thirteen months 




Figure 25: Daily COVID-19  actual Deaths and predicted Deaths for the thirteen months and the 
next seven days’ forecasted deaths by ARIMA model (p+d = 1, q = (1, 6, 7 )) based on the 
female. 
Here, the daily COVID-19 actual and predicted deaths of females for thirteen months have 
been compared and seven day’s forecasted deaths based on the developed model are shown. 
Then the evaluation metrics for this ARIMA model have been performed, which indicates 
that MAE and RMSE of the developed model-based separately on females and males are lower 
than that of the ARIMA model developed for the aggregate data on gender.  
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Table 19: Evaluation Metrics for the developed ARIMA Model for COVID-19  Deaths based on 
Gender 
Evaluation Metrics for the ARIMA model (p = 0, d = 1, and q = (1, 6, 7)) of 
Thirteen Months COVID-19  Deaths 
 Values not Based on 
Gender 
Male Female 
Mean Absolute Error 
(MAE) 
17.84 10.38 9.29 
Root Mean Squared 
Error (RMSE) 
25.56 14.59 13.34 
 
5.6 Forecasting for COVID-19 log_Cases  
 
In above, the study results of the COVID-19  log_Deaths variable have been discussed to 
evaluate the performance of proc arima’s IDENTIFY statements. Now the same analysis is done 
by using COVID-19  log_Cases in Florida. The findings results are discussed below. 
In figure 26 daily COVID-19  log_Cases in Florida is shown, where the highest peak was 
in January 2021. As there are identification stage, estimation, and diagnostic checking stage, and 
forecasting stage in the ARIMA model, the gotten results of those three stages are discussed below 




Figure 26: COVID-19  log_Cases is shown as a function of the Date 
5.6.1 Model Identification for log_Cases variables 
For getting stationary data the period of differencing 1 has been used in this IDENTIFY 
stage, where the mean of COVID_19 log_Cases is 0.016 that is close to zero, the standard deviation 






Table 20: Descriptive Statistics for log_Cases series. 
Name of Variable = log_Cases 
Period(s) of Differencing 1 
Mean of Working Series 0.016087 
Standard Deviation 0.36009 
Number of Observations 414 
Observation(s) eliminated by differencing 1 
 
In table 21, it can be seen that the log_Cases series data is without white noise as the p-
value for the first six lags are less than the alpha value,0.05. therefore, a model with log_Cases 
series is built. 
 
Table 21: Autocorrelation Analysis of log_Cases series. 
Autocorrelation Check for White Noise 
To Lag Chi-Square DF Pr > ChiSq Autocorrelations 
6 71.35 6 <.0001 -0.392 0.048 -0.094 0.034 -0.072 0.002 
12 111.46 12 <.0001 0.264 0.064 -0.063 -0.074 -0.081 0.069 
18 177.63 18 <.0001 -0.105 0.339 -0.087 0.032 -0.082 -0.110 
24 220.65 24 <.0001 0.031 -0.047 0.275 -0.074 0.020 -0.115 
 
To make sure whether the log_cases series have stationarity, ACF plot that shows that ACF 
decay slowly and autocorrelation in this plot changes, and the Augmented Dickey-Fuller (ADF) 
tests, where p-values of the tau test for all zero mean, single mean, and trend are less than alpha 








Figure 27: Autocorrelation Analysis Plots for stationary series of the log_Cases. 
                             Table 22: Augmented Dickey-Fuller (ADF) Tests for log_Cases variable 
Augmented Dickey-Fuller Unit Root Tests 
Type Lags Rho Pr < Rho Tau Pr < Tau F Pr > F 
Zero Mean 0 -573.797 0.0001 -31.14 <.0001     
  1 -761.906 0.0001 -20.04 <.0001     
Single Mean 0 -574.788 0.0001 -31.18 <.0001 486.07 0.0010 
  1 -769.000 0.0001 -20.09 <.0001 201.92 0.0010 
Trend 0 -577.003 0.0001 -31.31 <.0001 490.24 0.0010 
  1 -784.541 0.0001 -20.24 <.0001 204.83 0.0010 
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Then the Extended Sample Autocorrelation Function (ESACF) table has been used to get 
SAS suggestions for p, d, and q values. Then forecasting the next seven day’s value of log_Cases 
for six months (March 12, 2020, to September 10, 2021), and nine months (March 12, 2020, to 
December 06, 2021) models and comparing those forecasted value with the actual value the 
performance of those recommended parameters have been justified. Besides that, the next seven 
day’s value of log_Cases has been found for thirteen months(March 12, 2020, to April 30, 2021) 
model. 
Table 23: SAS recommended ESACF (Extended Sample Autocorrelation Function) Tables for 
parameters p, d, and q 
 
Table 23 shows SAS recommended parameters to fit one or more ARIMA models for the 




5.6.2 Estimation and diagnostic checking for log_Cases variable 
 
In the estimate stage, SAS recommended parameters have been used to build models and 
among those, the best performer models have been chosen based on the AIC  value, and the SBC 
value of those models. As shown in the previous discussion for obtaining the final model, the 
ARIMA models with parameters that have the lowest AIC and SBC values have been chosen to 
build the model, in this section similar work is also done for the ARIMA model of COVID-19  
cases. 
However, after building models with those parameters, it has been figured out that the 
MA1,1; MA1,4; and MA1,6 are significant parameters at alpha 0.05 for six months, nine months, 
and thirteen months data based on Maximum Likelihood Estimation tables. Therefore, p = 0, d = 
1, and q = (1, 4, 6) parameters are taken to fit the ARIMA models for all three periods of months. 
The fitted equation for all three periods of months are given below: 
Fitted equation of ARIMA model (p = 0, d = 1, and q = (1, 4, 6 ) for Six months data: 
𝑧𝑡 =  𝑒𝑡 − 0.52866𝑒𝑡−1 +  0.17001𝑒𝑡−4 + 0.20508𝑒𝑡−6                               (7) 
Fitted equation of ARIMA model (p = 0, d = 1, and q = (1, 4, 6 ) for Nine months data: 
𝑧𝑡 =  𝑒𝑡 − 0.61926𝑒𝑡−1 + 0.13499 𝑒𝑡−4 + 0.20144𝑒𝑡−6                               (8) 
Fitted equation of ARIMA model (p = 0, d = 1, and q = (1, 4, 6 ) for Thirteen months data:     




Then the autocorrelation of residuals has been checked to be sure about the model’s 
adequacy for this log_Cases series. As the p-values of the first six lags are higher than the alpha 
value 0.05, the null hypothesis-no-autocorrelation hypothesis is not rejected for the developed 
ARIMA model of all three periods of months (first six months, nine months, and thirteen months). 
So the ARIMA models with parameters (p = 0, d = 1,  q = (1, 4, 6 )) are adequate to do this analysis 
for all three periods of data. Normality plots show that the normality of residuals has also been 
maintained by this ARIMA model (p +d = 1, q = (1, 4, 6)) for all three periods of months.  
5.6.3 Forecasting for Six months   
By using FORECAST statements in the ARIMA model (p = 0, d = 1, q = (1, 4, 6 )) next 
seven day’s forecasted values have been found for six months, nine months, and thirteen months. 
The gotten results have been discussed below:  
Table 24: Forecast for the ARIMA(p=0, d=1, q=(1, 4, 6 )) model for log_Cases variable of the first 
six month’s data. 
Forecasts for variable log_Cases for First Six Months 
Obs Forecast Std Error 95% Confidence Limits 
184 7.8119 0.3199 7.1849 8.4388 
185 7.6869 0.3536 6.9939 8.3800 
186 7.6537 0.3844 6.9003 8.4072 
187 7.7675 0.4129 6.9582 8.5768 
188 7.8013 0.4611 6.8976 8.7050 
189 7.9179 0.5047 6.9288 8.9070 





Table 24 represents the forecasted values of the log_Cases for the next seven days, where the 
log_Cases would be increased.  
 
Figure 28: Forecast of log_ Cases for the ARIMA model (p = 0, d = 1, q = (1, 4, 6 )) for next 7 
days first six month’s data with 95% confidence limits. 
To evaluated the ARIMA model’s predicted performance, the actual values of log_Cases 






Figure 29: First six months’ daily COVID-19  actual log_cases, and predicted and forecasted 
log_cases for the next seven days in Florida. 
Figure 30 shows Comparing daily COVID-19  actual deaths and predicted deaths for the 
first six months and forecasted Cases for the next seven days, where without log-transformed data 
has been used. When the actual cases have been compared with the developed model’s forecasted 
cases, it has been seen that the actual cases were increasing from September 11 to September 17, 
2021. Therefore, the developed ARIMA model ( p = 0, d = 1, q = (1, 4, 6 ) performing well to 




Figure 30: Comparing daily COVID-19  actual deaths and predicted deaths for the first six 
months and forecasted Cases for the next seven days. 
5.6.4 Forecasting for Nine months 
 For nine months data same analysis like as previous has been done. From table 25 it is 
obvious that log_Cases for the next seven days would be decreased. 
Figure 31 shows forecasting of COVID-19  for log_Cases, where the number of log_Cases 







Table 25: Forecast for the ARIMA (p = 0, d = 1,  q = (1, 4, 6 )) model for log_Cases variable of 
the first nine month’s data. 
Forecasts for variable log_Cases for Nine Months 
Obs Forecast Std Error 95% Confidence Limits 
271 9.2097 0.3189 8.5846 9.8347 
272 9.2716 0.3412 8.6028 9.9404 
273 9.2745 0.3622 8.5646 9.9844 
274 9.2437 0.3820 8.4949 9.9924 
275 9.2029 0.4159 8.3877 10.0181 
276 9.1408 0.4473 8.2642 10.0174 





Figure 31: Forecast of log_Cases for the ARIMA model (p = 0, d = 1, and q = (1, 4, 6 )) for the 




Figure 32: Daily COVID-19  actual log_Cases and predicted log_Cases for the first Nine  
months and forecasted log_Cases for the next seven days 
  In figure 32, the log of daily COVID-19  actual Cases and the predicted cases are shown 
for the first 9 months, where it is obvious that the actual and predicted COVID-19  cases are fairly 
comparable with each other. In the last part of the graph, which is indicated with the red dash, is 
shown the forecasting value for 7 days based on the prediction made in the last nine months of 




Figure 33: Comparing the daily actual COVID-19  Cases with forecasted COVID-19  Cases for 
the first nine months with seven days forecasting value. 
In figure 33, the daily actual COVID-19  cases are compared with the forecasted COVID-
19  cases for seven days, where this forecasting has been done based on the prediction on the last 
nine months of COVID-19  cases. This prediction is made from the actual COVID-19  cases of the 
last nine months. In this figure, it is found that seven days actual COVID-19  cases are supporting 




5.6.5 Forecasting for Thirteen months 
Developed ARIMA model for thirteen months has been given seven days forecasted values 
than are shown in table 25, from where it can be seen that number of the log_cases would be 
increasing for next seven day. 
Table 26: Forecast for the ARIMA (p = 0, d = 1, q = (1, 4, 6 )) model for log_Cases variable of 
the first nine month’s data. 
Forecasts for variable log_Cases for Thirteen Months 
Obs Forecast Std Error 95% Confidence Limits 
416 8.4613 0.3024 7.8686 9.0540 
417 8.5039 0.3201 7.8764 9.1314 
418 8.5124 0.3370 7.8519 9.1728 
419 8.5619 0.3530 7.8701 9.2537 
420 8.5653 0.3727 7.8349 9.2957 
421 8.5829 0.3914 7.8158 9.3500 






Figure 34: Forecast of log_Cases for the ARIMA model (p = 0, d = 1,  q = (1, 6, 7)) for the next 
7 days of the first nine months’ data with 95% confidence limits. 
To represent the increase of COVID-19  log_Cases, figure 36 has been drowned below, 




Figure 35: Daily COVID-19  actual log_Cases and predicted log_Cases for the thirteen months 
and forecasted log_Cases for the next seven days 
Figure 35 shows that the daily actual log_Cases and daily predicted log_Cases are showing 
similar patterns over thirteen months. Therefore, it can be assumed that the performance of this 
model is good. To justify the model performance figure 37 has been shown below, where data 




Figure 36: Daily COVID-19  actual Cases and predicted Cases for the thirteen months and 
forecasted Cases for the next seven days 
Figure 36 shows that COVID-19 actual Cases and predicted cases for thirteen months are 
showing approximately similar ups and downs. 
After observing the previous analysis for COVID-19  Cases, it seems that the developed 
ARIMA model (p = 0, d = 1,  q = (1, 4, 6 )) is performing well. However, to compare these three-
period models with other published works, MAE (Mean Absolute Error) and RMSE (Root Mean 
Squared Error)  have been used. In table 26, MAE values and RMSE values are given for six 
months, nine months, and thirteen months’ duration. One journal [4] reported that MAE for 
COVID-19  cases is 2967 in the ARIMA model (p+d = 23, q = 22) for January 20, 2020, to May 
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21, 2020. Another journal [5] claimed that MSE for ARIMA model (p+d = 1, q = 0) is 
7240024855.066816 for March to June 26, 2020. 
Here, it is found that MAE and RMSE for other ARIMA models are higher than that of the 
ARIMA model (p+d = 1, q =(1, 4, 6)), which has been developed in this study. Therefore, the 
developed models for three periods of months that are forecasted the number of COVID-19  cases 
for a short-term duration, which is 7 days in this study, fairly to conduct this type of analysis in 
future with more datasets. 
Table 27: Evaluation Metrics for the developed ARIMA Model for COVID-19  Cases 
 
Evaluation Metrics for the ARIMA Model (p = 0, d = 1,  q = (1, 4, 6 )) 
for COVID-19  Cases 
 Six Months Nine Months Thirteen Months 
Mean Absolute Error (MAE) 740.02 1035.75 1074.88 
Root Mean Squared Error 
(RMSE) 
1232.17 2006.87 1680.19 
 
Satrio et at [4] shows in their study  that MAE is 2967 for ARIMA model (p+d = 23, q = 22) 
of COVID-19  cases. 





The findings of exploratory data analysis that suggests higher COVID-19 cases for females 
compared to males across all time points considered in this thesis are taken into consideration by 
evaluating the performance of final models by gender. It was noted in the exploratory data analysis 
section that the total number of COVID-19 cases and the daily number of COVID-19 cases are 
higher for females than that of males in Florida. Therefore, females are more affected by COVID-
19  compare to males in Florida. To explore further how gender relates to cases in Florida 
developed ARIMA model (p = 0, d = 1,  q = (1, 4, 6 )) of thirteen months has been run for male 
and female separately, where the AIC and SBC values for the models based on females, and based 
on males are lower than the model that is not based on gender.  
 
Figure 37: Daily COVID-19  actual Cases and predicted Cases for the thirteen months and 




To show the seven days’ forecasting performance of the ARIMA model (p = 0, d = 1, q = 
(1, 4, 6 )) based on gender the following figures 37 and 38 have been drawn.  
It is obvious from figure 38 that daily COVID -19 Cases and predicted Cases for males are 
showing approximately similar ups and downs. And the forecasted seven days’ value shows that 
the number of Cases for males would be increased for those days. 
 
Figure 38: Daily COVID-19  actual Cases and predicted Cases for the thirteen months and 
forecasted Cases for the next seven days by ARIMA model (p = 0, d = 1,  q = (1, 4, 6 )) based on 
females. 
Figure 38 represents that actual and predicted Cases for females are close enough that it 
can be said that the developed model is showing quite satisfying performance. 
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Now the evaluation metrics for the ARIMA model(p = 0, d = 1, q = (1, 4, 6 ) with 
considering gender also have been done to see the MAE and RMSE values. From table 27 it can 
be seen that the MAE and RMSE of the developed model that is based on gender are lower than 
that of the ARIMA model which is not based on gender.  
Table 28: Evaluation Metrics for the developed ARIMA Model for COVID-19  Cases based on 
Gender 
Evaluation Metrics for the ARIMA model (p = 0, d = 1, and q = (1, 4, 6 )) of 
Thirteen Months COVID-19  Cases 
 Values not Based on 
Gender 
Male Female 
Mean Absolute Error 
(MAE) 
1074.88 500.32 563 
Root Mean Squared 
Error (RMSE) 
1680.19 775.019 881.95 
 
Therefore, the gender-specific models appear to be better under both model comparison 
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CHAPTER 6: CONCLUSION  
COVID-19 pandemic has caused massive disruption to our current world. The impact and 
enormous scale of this crisis causing a lot of fear, uncertainty, and anxiety across the whole world. 
Therefore, it is crucial to understand the COVID-19 pandemic and its impacts on our society to 
avoid future losses. In the study, an Evaluation of the Performance of Proc Arima’s Identify 
Statement: A Data-driven Approach using Covid-19 Cases and Deaths in Florida, it can be seen 
that the developed statistical ARIMA models have been performing well to better understand the 
COVID-19 pandemic in one of the major states, Florida, in the United States.  
For this study, data has been transformed into logarithmic and differencing forms so that 
the stationarity of data can be achieved. To build ARIMA models for COVID-19 Deaths and Cases 
ESACF (Extended Sample Autocorrelation Function) tables have been used where different SAS 
suggestions for model parameters p (the order of the Autoregressive model), d (the order of the 
differencing), and q (the order of the Moving Average model) have been considered for the given 
values of p, d, and q. We have used p = 4, d = 1, and q = 8 as starting values for model identification.  
To do this analysis ARIMA models have been developed, such as the ARIMA model (p = 
0, d = 1,  q = (1, 4, 6 )) for COVID-19 log_Cases, and ARIMA model (p = 0, d = 1,  q = (1, 6, 7)) 
for COVID-19 log_Deaths, based on the suggestion that proc arima’s IDENTIFY statement 
provided for COVID-19 log_Deaths and log_Cases data of six months, nine months and thirteen 
months. 
Then short-term (seven days) COVID-19 deaths and cases have been forecasted by those 
models and compared the forecasted values with the actual values of the COVID-19 deaths and 
cases to evaluate these ARIMA models’ performance. MAE and RMSE have been also considered 
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to justify the models. Besides these deaths and case variables, gender variables also consider 
building model that helps to get more accurate models with low MAE and RMSE values. 
 This selecting and building process of the ARIMA model with the COVID-19 dataset help 
to test and compare the accuracy and make an optimal selection among other models that are used 
in different research works for the COVID-19 dataset. Even though the previous publications have 
mainly focused to forecast the COVID-19 cases and deaths for a long period, the accuracy rates of 
those models are not satisfactory because of using a small size of data. Besides that, as it is an 
ongoing pandemic, many variables can come to change the number of COVID-19 deaths and 
cases. Therefore, forecasting the long time COVID-19 deaths and cases just based on  COVID-19 
Deaths and Cases variables are not enough. However, in this study large size of data is used to 
develop models to forecast the seven-day’s COVID-19 Deaths and Cases with negligible errors.  
The gotten results show that the ARIMA model has achieved good performance in the 
COVID-19 deaths and cases for Florida. Therefore, this type of model could be helpful in the 
instance where time and needed supplies are limited regarding the progress of the epidemic in any 
county or worldwide for short-term forecasting. On the other hand, this short-term forecasting can 
be useful for travel agencies, small businesses, education sectors, and hospitals, etc. to make short-
term planning.  
However, this model can be more robust and useful for COVID-19 data analysis when age 
group and gender are taken into consideration in the development of the prediction model. Besides 
there is a possibility for the spread of this virus during holidays (including weekends), parties, and 
other social events. We have chosen q = 8 so that the weekends were not missed from any of the 
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suggested models. Other starting values of the parameters p, d, and q may be considered for future 
research on the analysis of COVID-19 data and modeling approaches.  
 
 
